Home Page  
    Advanced
Search
Home Page Corporate Services Careers Specialties Strategic Alliances Events & Speakers Investigators Study Volunteers Contact

  Antiviral/Anti-Infective

  Cardiovascular

  Central Nervous System

  Critical Care

  Dental Pain Research

  Device/Diagnostic Studies

>Endocrine/Metabolic

  Gov/NGO PharmaServices

  Hematology/Oncology

  Immunology

  Ophthalmology

  Vaccine Development

Endocrine and Metabolic Studies

Utilize PPD’s specialized therapeutic expertise and study experience to manage multinational clinical trials for a broad range of endocrine and metabolic indications and therapies. We provide expert resources around the world for efficient and cost-conscious drug development — from the assembly of clinical trial applications through multinational regulatory approval and post-approval positioning.

Expertise for Challenging Clinical Studies

A dedicated project team assigned to your study ensures continuity for its duration. We provide:

  • Expertise based on a broad range of endocrine and metabolic disorder/clinical studies
  • Global experience, supported by automated query resolution
  • Expedited patient and investigator recruitment
  • Multinational regulatory expertise

Rapid Access to Specialized Investigators

PPD has a versatile investigator database containing more than 22,000 investigators worldwide as well as background and project-related performance data of sites in use. More than 65 percent of these investigators have participated in a PPD-managed trial, and many are experienced in conducting endocrinology clinical research trials.

Experience with a Broad Range of Endocrine and Metabolic Studies

We effectively manage Phase I-IV multinational studies for our clients across a broad range of indications and therapies:

  • Diabetes mellitus
  • Endocrine hypertension
  • Growth factors
  • Hormone replacement therapy
  • Lipid disorders
  • Obesity
  • Osteoporosis
  • Thyroid disorders

Phase Indication Sites Subjects Countries
II Hormone replacement and low libido
21
220
Australia, France, Germany, Italy, The Netherlands, United Kingdom
II Hormone replacement and low libido
26
160
Australia, France, Germany, Italy, The Netherlands, United Kingdom
III Diabetes mellitus and sexual dysfunction
20
254
United States
III Diabetes mellitus and sexual dysfunction
140
642
Austria, and Denmark, Germany, Israel, Norway, Poland, Russia, South Africa, United Kingdom
III Type 2 diabetes, pediatric
50
48
United States
III Diabetes mellitus
52
240
Belgium, Finland, Israel, South Africa, The Netherlands, United Kingdom
III Diabetes mellitus
67
312
United States
III Type 2 diabetes, pediatric
33
110
Poland, Russia, United States
III Type 2 diabetes, pediatric
196
82
Belgium, The Netherlands, Sweden, United Kingdom
III Hirsutism
8
101
Belgium, Denmark, Italy
III Osteoporosis, post menopausal
4
474
France, Germany, Denmark, United Kingdom
III Osteoporosis, post menopausal
12
300
United States
III Osteoporosis, population sampling
4
832
United States
III Osteoporosis, post menopausal
10
615
United States
III Osteoporosis, post menopausal
10
149
United States
III Osteoporosis, post menopausal
13
136
United States
III Osteoporosis, post menopausal
1
58
United States
III Osteoporosis, post menopausal
30
1,129
United States
III Osteoporosis, post menopausal
38
998
United States
III Osteoporosis and hip fracture
1
3,000
United States
III Obesity in hypertensives
40
550
United States
III Obesity in diabetics
41
536
United States
IV Obesity in diabetics
34
296
United States
IV Hormone replacement
5
384
United States
IV Hormone replacement
12
150
United States
IV Hormone replacement
5
220
United States


Investigators by Indication

Investigator Interest by Indication Total Specialists in Endocrinology
Diabetes mellitus
1,391
136
Endocrine hypertension
1,054
87
Growth factors
223
28
Hormone replacement
482
45
Lipid disorders
652
199
Obesity
370
51
Osteoporosis
435
83
Thyroid disorders
182
72
PPD Endocrine and Metabolic Studies